do not combine glp-1 receptor agonists with dpp-4 inhibitors guideline The effect of DPP Drug mechanism of action of
Description
However, in some individuals, the food intake control mechanism does not achieve this balance, leading to eating disorders and obesity

Rapid weight loss has been associated with gallbladder-related disorders including cholelithiasis and cholecystitis [67, 68], and these adverse events, while rare, have been observed more with GLP-1RAs compared with placebo in clinical trials [21, 38]
A steady dose

doi: 10.1001/archinternmed.2009.266 [DOI] [PMC free article] [PubMed] [Google Scholar] 15.Blackman A Foster GD Zammit G, et al
Regulatory environment supports continued innovation in obesity treatment with streamlined approval pathways for novel GLP-1 formulations
